Fortrea launches Fortrea Intelligent Technology (FIT), an AI-powered suite built on Xcellerate to automate workflows, enhance oversight, and improve efficiency across clinical trial operations.
Written By: Nikita Jha, BPharm
Reviewed By: Pharmacally Editorial Team
Fortrea has introduced Fortrea Intelligent Technology (FIT), a new suite of technology solutions designed to improve efficiency and oversight across clinical trial operations. The platform integrates persona-driven, AI-powered tools that automate workflows, streamline trial management, and support faster, more predictable study execution for sponsors, investigator sites, and project teams.
Integrated Technology Suite for Clinical Development
FIT builds on existing Fortrea offerings, including the Xcellerate platform, while adding newly developed tools that connect processes across the clinical trial ecosystem. The suite supports biopharma, biotech, and medical device development programs across clinical pharmacology and clinical development activities. It can be deployed in full-service or functional service models, with selected components available as software-as-a-service.
FIT is organized into three functional pillars:
- Lifecycle: Solutions designed to accelerate trial progression from pre-award activities to final electronic trial master file (eTMF), with automation of key operational steps.
- Foresight: Data-driven tools that provide trend analysis, dashboards, and near-real-time insights to support decision-making and risk mitigation.
- Companion: AI-powered applications built around user roles to enhance productivity, collaboration, and study execution.
Executive Perspective on AI-Driven Trial Operations
Chief Information Officer Alejandro Martinez Galindo said the platform combines advances in clinical trial methodology with modern technology. He noted that FIT was developed using sponsor and investigator feedback and is intended to help stakeholders conduct trials more efficiently while reducing operational risk.
Xcellerate Platform Forms the Foundation
The FIT suite is anchored by Fortrea’s Xcellerate platform, which supports risk-based quality management, central monitoring, and trial oversight. Recent enhancements provide role-based insights by integrating data across the trial environment. Embedded AI and machine learning capabilities analyze patterns, generate predictive signals, and initiate automated workflows to reduce manual effort.
Chief Operating Officer and President of Clinical Development Mark Morais stated that the enhancements aim to strengthen collaboration and responsiveness across study teams. He emphasized that responsible use of AI within FIT can help accelerate decision-making and improve the delivery of clinical research programs.
Fortrea said it plans to expand the FIT portfolio with additional technology solutions in future releases.
Reference
Fortrea Unveils Fortrea Intelligent Technology™ to Help Sponsors and Sites Run Smarter, More Integrated Trials, 07 April 2026, Fortrea Unveils Fortrea Intelligent Technology™ to Help Sponsors and Sites Run Smarter, More Integrated Trials | Fortrea
About the Writer
Nikita Jha BPharm is a pharmacy graduate with expertise in clinical research, pharmacovigilance, and medical writing. In her words, she is passionate about translating complex scientific data into clear, accurate healthcare communications that advance drug safety and patient care.
